Douglas Evans

Douglas Evans

Chairman chez TELA BIO, INC.

Fortune : 35 551 $ au 31/03/2024

59 ans
Health Technology
Consumer Services

Profil

Douglas G.
Evans
is the founder of Cure4Cam Childhood Cancer Foundation.
He currently holds multiple positions including President, CEO & Director at Lungpacer Medical, Inc., Chairman at TELA Bio, Inc., Director at Intact Vascular, Inc., and Director at White Swell Medical Ltd.
Previously, he served as COO & Director at DSM Biomedical, Inc. from 1989 to 2012 and as Director at Intact Vascular, Inc. from 2013 to 2020.
Evans has a graduate degree from the University of Pennsylvania, an undergraduate degree from The Pennsylvania State University, and an MBA from Penn State Great Valley.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/06/2023 6 270 ( 0,03% ) 35 551 $ 31/03/2024

Postes actifs de Douglas Evans

SociétésPosteDébut
TELA BIO, INC. Chairman 20/04/2020
Chief Executive Officer 01/01/2014
White Swell Medical Ltd. Director/Board Member 01/01/2016
Director/Board Member -
Tous les postes actifs de Douglas Evans

Anciens postes connus de Douglas Evans

SociétésPosteFin
Director/Board Member 01/09/2020
Chief Operating Officer 01/05/2012
Cure4Cam Childhood Cancer Foundation Founder -
Voir l'expérience en détail de Douglas Evans

Formation de Douglas Evans

University of Pennsylvania Graduate Degree
The Pennsylvania State University Undergraduate Degree
Penn State Great Valley Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Douglas Evans

Relations

73

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
TELA BIO, INC.

Health Technology

Entreprise privées5

Health Technology

Health Technology

Health Technology

White Swell Medical Ltd.

Cure4Cam Childhood Cancer Foundation

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Douglas Evans